Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
Send patient prescriber agreement form via email, link, or fax. You can also download it, export it or print it out.
How to use or fill out Patient-Prescriber Agreement Form - TIRF REMS with DocHub
Ease of Setup
DocHub User Ratings on G2
Ease of Use
DocHub User Ratings on G2
Click ‘Get Form’ to open the Patient-Prescriber Agreement Form in our editor.
Begin by filling out the prescriber section. Enter your first and last name, DEA number, National Provider Identifier (NPI), and fax number. Ensure all required fields are completed.
Review the acknowledgment statements regarding TIRF medicines carefully. Check each box to confirm your understanding of the risks and responsibilities associated with prescribing TIRF medications.
Next, move to the patient section. The patient or their representative should provide their signature, name, date of birth, and contact information. Make sure all required fields are filled out accurately.
Once all sections are complete, review the entire form for accuracy. Use our platform’s tools to make any necessary edits before finalizing.
Finally, save your completed form and choose to either print it for fax submission or share it directly via email if needed.
Start using our platform today to streamline your document editing and signing process for free!
Fill out Patient-Prescriber Agreement Form - TIRF REMS online It's free
A Risk Evaluation and Mitigation Strategy (REMS) is a drug safety program that the U.S. Food and Drug Administration (FDA) can require for certain medications with serious safety concerns to help ensure the benefits of the medication outweigh its risks.
What does tirf mean in medical terms?
TIRF (transmucosal immediate-release fentanyl) medicines contain fentanyl, a prescription opioid pain reliever. TIRF medicines are used to manage breakthrough pain in adults with cancer who are routinely taking other opioid pain medicines around-the-clock for pain.
What is the Tirf rems program?
The Transmucosal Immediate Release Fentanyl (TIRF) Risk Evaluation and Mitigation Strategy (REMS) Program is an FDA-required program designed to ensure informed risk-benefit decisions before initiating treatment, and while patients are treated to ensure appropriate use of TIRF medicines.
What is the purpose of the Tirf program?
The purpose of the TIRF REMS Access program is to mitigate the risk of misuse, abuse, addiction, overdose and serious complications due to medication errors with the use of TIRF medicines.
fda drug authority
memorandum
Jun 1, 2012 This memo serves as documentation of agreement between OSE/DRISK and the sponsors of the. TIRF REMS Access program for the first modification of
Federal Regulatory Responses to the Prescription Opioid
by L Noah 2019 Cited by 30 use are specially certified, and that completion of the prescriber-patient agreement form occurs prior to dispensing TIRF medicines for outpatient use.117
Cookie consent notice
This site uses cookies to enhance site navigation and personalize your experience.
By using this site you agree to our use of cookies as described in our Privacy Notice.
You can modify your selections by visiting our Cookie and Advertising Notice.
